Search results

  1. Starting with the end in mind - the Innovative Licensing and Access Pathway

    Launched in January, the new Innovative Licensing and Access Pathway (ILAP) will smooth the process by which innovative new medicines are developed, speeding their progression from clinical trial through to the NHS. It is an exciting development that signals greater collaboration between the agencies involved and, we hope, should bring significant benefits to patients.

  2. NICE welcomes appointment of six new Board members

    NICE is delighted with today’s (15 March) announcement from the Department of Health & Social Care appointing six new non-executive directors to its Board following their approval by the Secretary of State.